{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "73581-204",
      "generic_name": "PHENYLPHRINE HCL",
      "labeler_name": "YYBA CORP",
      "brand_name": "NASAL DECONGESTANT PE 10mg",
      "brand_name_suffix": "10mg",
      "active_ingredients": [
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "73581-204-02",
          "description": "200 TABLET in 1 BOTTLE (73581-204-02)",
          "marketing_start_date": "20210803",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "YYBA CORP"
        ],
        "spl_set_id": [
          "05824fc4-ef3f-4ebb-b601-252f76ad60ef"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET",
      "spl_id": "0e13a1f1-87bb-b26e-e063-6294a90a87f8",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210803",
      "product_id": "73581-204_0e13a1f1-87bb-b26e-e063-6294a90a87f8",
      "application_number": "M012",
      "brand_name_base": "NASAL DECONGESTANT PE",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}